Pulsed-field vs. Cryoballoon vs. Radiofrequency ablation: outcomes after pulmonary vein isolation in patients with persistent atrial fibrillation
Pulsed-field ablation (PFA) has shown promising data in terms of safety and procedural efficiency for pulmonary vein isolation (PVI), with similar long-term outcomes compared to radiofrequency ablation (RFA) and cryoballoon ablation (CBA) in patient with paroxysmal atrial fibrillation (AF) (Source: Heart Rhythm)
Source: Heart Rhythm - April 10, 2024 Category: Cardiology Authors: Thomas Kueffer, Robin Stettler, Jens Maurhofer, Antonio Madaffari, Anita Stefanova, Salik ur Rehman Iqbal, Gregor Thalmann, Nikola A. Kozhuharov, Oskar Galuszka, Helge Servatius, Andreas Haeberlin, Fabian Noti, Hildegard Tanner, Laurent Roten, Tobias Reic Source Type: research
Acute Kidney Injury after Catheter Ablation of Atrial Fibrillation: Comparison between Different Energy Sources
Pulsed field ablation (PFA) is an innovative technology recently adopted for treating atrial fibrillation (AF). Preclinical and clinical studies have reported a reassuring safety profile because of its tissue-specific effect, sparing adjacent tissues.1 However, two cases of acute kidney injury (AKI) secondary to hemolysis after PFA have recently been reported after an uncommonly high number of applications.2,3 Similarly, a subsequent pilot study reported the occurrence of AKI in 4/28 patients after PFA for AF. (Source: Heart Rhythm)
Source: Heart Rhythm - April 10, 2024 Category: Cardiology Authors: Fabian Jordan, Sven Knecht, Corinne Isenegger, Rebecca Arnet, Philipp Krisai, Gian V öllmin, Jeanne du Fay de Lavallaz, David Spreen, Stefan Osswald, Christian Sticherling, Michael Kühne, Patrick Badertscher Source Type: research
Left bundle branch block-induced cardiomyopathy: a distinctive form of cardiomyopathy that might require a dedicated form of treatment.
The His-Purkinje system is the ventricular component of the cardiac conduction system that orchestrates the electrical impulse propagation which underlies every contraction of the heart. It originates from the AV-node and runs down to the interventricular septum and subdivides into the left and right bundle branches. These major branches divide further and spread diffusely along the sub endocardium. [1],[2] Damage in one of those branches may result in impaired electrical conduction. (Source: Heart Rhythm)
Source: Heart Rhythm - April 10, 2024 Category: Cardiology Authors: Manon Kloosterman, K.Peter Loh, Toon A.B. van Veen Source Type: research
Feasibility and efficacy of real-time ultrasound-guided venous closure with suture-mediated vascular closure device
Complications of venous vascular access are usually non-fatal but are the most common complications after transvenous catheter intervention. Vascular closure devices (VCD) have recently become available for venous closure. (Source: Heart Rhythm)
Source: Heart Rhythm - April 10, 2024 Category: Cardiology Authors: Masaya Tachi, Akihito Tanaka, Tsubasa Teraoka, Tappei Furuta, Etsushi Matsushita, Kazunori Hayashi, Masafumi Shimojo, Satoshi Yanagisawa, Yasuya Inden, Toyoaki Murohara Source Type: research
Relationship between wait-times and post-atrial fibrillation ablation outcomes: a population based study
Rhythm control is a cornerstone of atrial fibrillation (AF) management. Shorter time between diagnosis of AF and receipt of catheter ablation is associated with greater rates of therapy success. Prior work considered diagnosis-to-ablation time as a binary or categorical variable and did not consider the unique risk profile of patients once a referral for ablation is made. (Source: Heart Rhythm)
Source: Heart Rhythm - April 10, 2024 Category: Cardiology Authors: Denis Qeska, Feng Qiu, Ragavie Manoragavan, Harindra C. Wijeysundera, Christopher C. Cheung Source Type: research
Electrophysiologic mechanism and ablation strategy for macroreentrant biatrial tachycardias after Cox-maze procedures
Different types of recurrent atrial tachycardia (AT) after Cox-maze procedures have been reported, whereas biatrial tachycardia (BiAT) has not been systematically analyzed. (Source: Heart Rhythm)
Source: Heart Rhythm - April 9, 2024 Category: Cardiology Authors: Jinlin Zhang, Guanghui Cheng, Chenggang Deng, Anquan Zhao Source Type: research
Prognosis of patients in end-stage heart failure with atrial fibrillation treated with ablation: Insights from CASTLE-HTx
The CASTLE-HTx trial demonstrated the benefit of atrial fibrillation (AF) ablation compared with medical therapy in decreasing mortality, need for left ventricular assist device implantation, or heart transplantation (HTx) in patients with end-stage heart failure (HF). (Source: Heart Rhythm)
Source: Heart Rhythm - April 9, 2024 Category: Cardiology Authors: Maximilian Moersdorf, Jan G.P. Tijssen, Nassir F. Marrouche, Harry J.G.M. Crijns, Angelika Costard-Jaeckle, Leonard Bergau, Gerhard Hindricks, Nikolaos Dagres, Samuel Sossalla, Rene Schramm, Henrik Fox, Thomas Fink, Mustapha El Hamriti, Vanessa Sciacca, F Source Type: research
Prognostic significance of beat-to-beat variability of spatial heterogeneity of repolarization analyzed from a 5-minute resting electrocardiogram in coronary artery disease
Data on the prognostic significance of temporal variability of spatial heterogeneity of electrocardiographic repolarization in coronary artery disease (CAD) are limited. (Source: Heart Rhythm)
Source: Heart Rhythm - April 9, 2024 Category: Cardiology Authors: Janne T. Rahola, Severi M. Mattila, Antti M. Kiviniemi, Olavi H. Ukkola, Mikko P. Tulppo, M. Juhani Junttila, Heikki V. Huikuri, Tuomas V. Kentt ä, Juha S. Perkiömäki Source Type: research
Regional Differences in the Outcomes of Catheter Ablation for Atrial Fibrillation in the United States
We examined such variations by analyzing procedural complications and in-hospital outcomes among patients undergoing AF ablation utilizing the National Inpatient Sample (NIS), a collaborative effort between federal, state, and industry stakeholders sponsored by the Agency for Healthcare Research and Quality (AHRQ), captures hospital data from over 7 million discharges annually, representing approximately 20% of nonfederal hospital discharges across all 50 states (1). (Source: Heart Rhythm)
Source: Heart Rhythm - April 9, 2024 Category: Cardiology Authors: Siddharth Agarwal, Charu Debnath, Muhammad Bilal Munir, Christopher V. DeSimone, Abhishek Deshmukh, Zain Ul Abideen Asad Source Type: research
Clinical practice and outcome of S-ICD replacement: results from the multicenter RHYTHM DETECT registry.
We report our experience with S-ICD generator replacement within a large multicenter registry, describing current procedural practices and measuring acute and mid-term outcomes. (Source: Heart Rhythm)
Source: Heart Rhythm - April 9, 2024 Category: Cardiology Authors: Valter Bianchi, Pietro Francia, Giuseppe Ricciardi, Stefano Viani, Gerardo Nigro, Mauro Biffi, Paolo De Filippo, Luca Ottaviano, Federico Migliore, Alessandro Vicentini, Mariolina Lovecchio, Sergio Valsecchi, Antonio D ’Onofrio, Pietro Palmisano, "S-ICD Source Type: research
Atrioventricular Optimization Improves Cardiac Resynchronization Response in Patients with Long Interventricular Electrical Delays: A Pooled Analysis of the SMART-AV and SMART-CRT Trials
The utility of atrioventricular (AV) optimization (AVO) algorithms remains in question. A substudy of the SMART-AV trial found patients with prolonged interventricular (RV-LV) delays ≥70 ms were more likely to benefit from CRT with AVO. The SMART-CRT trial evaluated AVO based on these results, but the study was underpowered. (Source: Heart Rhythm)
Source: Heart Rhythm - April 9, 2024 Category: Cardiology Authors: Michael R. Gold, Angelo Auricchio, Christophe Leclercq, Nicholas Wold, Kenneth M. Stein, Kenneth A. Ellenbogen Source Type: research
Prognosis of patients in end-stage heart failure with atrial fibrillation treated with ablation - Insights from Castle HTX
The CASTLE-HTx trial demonstrated the benefit of atrial fibrillation (AF) ablation compared to medical therapy in decreasing mortality, need for left ventricular assist device (LVAD) implantation or heart transplantation (HTx) in patients with end-stage heart failure (HF). (Source: Heart Rhythm)
Source: Heart Rhythm - April 9, 2024 Category: Cardiology Authors: Maximilian Moersdorf, Jan G.P. Tijssen, Nassir F. Marrouche, Harry J.G.M. Crijns, Angelika Costard-Jaeckle, Leonard Bergau, Gerhard Hindricks, Nikolaos Dagres, Samuel Sossalla, Rene Schramm, Henrik Fox, Thomas Fink, Mustapha El Hamriti, Vanessa Sciacca, F Source Type: research
Reduced dementia risk in patients with optimized anticoagulation therapy undergoing atrial fibrillation ablation
Atrial fibrillation (AF) is associated with the development of dementia and observational studies have shown that oral anticoagulation (OAC) and catheter ablation reduce dementia risk. However, such studies did not consistently report on periprocedural anticoagulation and long term OAC coverage, for which reason the separate effect of AF ablation on dementia risk could not be established. (Source: Heart Rhythm)
Source: Heart Rhythm - April 9, 2024 Category: Cardiology Authors: Finn Åkerström, Emmanouil Charitakis, Astrid Paul-Nordin, Frieder Braunschweig, Leif Friberg, Fariborz Tabrizi, Mats Jensen-Urstad, Nikola Drca Source Type: research
Electrophysiological Mechanism and Ablation Strategy for Macro-reentrant Biatrial Tachycardias Following Cox-Maze Procedures
Different types of recurrent atrial tachycardias (ATs) following Cox-Maze procedures have been reported, while biatrial tachycardia (BiAT) have not been systematically analyzed. (Source: Heart Rhythm)
Source: Heart Rhythm - April 9, 2024 Category: Cardiology Authors: Jinlin Zhang, Guanghui Cheng, Chenggang Deng, Anquan Zhao Source Type: research
SVT with a variable RP relationship but without a change in the cycle length: What is the mechanism?
A 70-year-old male with a history of hypertension, hyperlipidemia, coronary artery disease, and CABG, presented with symptoms of moderate-intensity palpitations that terminated with Valsalva maneuvers. He was noted to have supraventricular tachycardia (SVT) on an event monitor. He had persistent symptoms despite treatment with beta-blockers. The ECGs recorded in the EP lab during the symptoms is shown in Figures 1A and 1B. What is the most likely etiology of the SVT? (Source: Heart Rhythm)
Source: Heart Rhythm - April 9, 2024 Category: Cardiology Authors: Sunil K. Vasireddi, Mannat Badhwar, Gerilyn Schott, Melvin Scheinman Source Type: research
